This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Bladder Carcinoma, Gastric Carcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Lung Carcinoma, Malignant Neoplasm
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Patient-Derived Xenografts to Reduce Cancer Health Disparities
-
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States, 92868
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States, 95817
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to 100 Years
ALL
No
University of California, Davis,
Luis G Carvajal-Carmona, PRINCIPAL_INVESTIGATOR, University of California, Davis
2024-12